Page last updated: 2024-08-24

cephalosporin c and tedizolid

cephalosporin c has been researched along with tedizolid in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	2 (66.67)	24.3611
2020's	1 (33.33)	2.80

Authors

Authors	Studies
Holmes, NE; Howden, BP	1
Arber, M; Barata, T; Eales, J; Fleetwood, K; Glanville, J; Gould, IM; Kauf, TL; McCool, R	1
Anguita-Santos, F; Aznarte-Padial, MP; Borreguero, I; Castón, JJ; Corzo-Delgado, JE; Esteban-Moreno, MÁ; Herrero-Rodríguez, C; Jiménez-Aguilar, P; López-Cárdenas, S; Maldonado, N; Martín-Aspas, A; Martínez-Marcos, FJ; Ojeda-Burgos, G; Palacios-Baena, ZR; Praena-Segovia, J; Retamar, P; Rodríguez-Baño, J; Rosso-Fernández, CM; Valiente de Santis, L	1

Reviews

2 review(s) available for cephalosporin c and tedizolid

Article	Year
What's new in the treatment of serious MRSA infection? Current opinion in infectious diseases, 2014, Volume: 27, Issue:6 Topics: Acetamides; Anti-Bacterial Agents; Cephalosporins; Cost-Benefit Analysis; Drug Administration Routes; Drug Therapy, Combination; Glycopeptides; Humans; Linezolid; Lipoglycopeptides; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Oxazolidinones; Severity of Illness Index; Skin Diseases, Bacterial; Staphylococcal Infections; Tetrazoles; Vancomycin	2014
Systematic review and network meta-analysis of tedizolid for the treatment of acute bacterial skin and skin structure infections caused by MRSA. BMC infectious diseases, 2017, 01-07, Volume: 17, Issue:1 Topics: Anti-Bacterial Agents; Bayes Theorem; Ceftaroline; Cephalosporins; Daptomycin; Humans; Linezolid; Methicillin-Resistant Staphylococcus aureus; Organophosphates; Oxazoles; Oxazolidinones; Skin Diseases, Bacterial; Staphylococcal Infections; Tetrazoles; Vancomycin	2017

Article

Year

What's new in the treatment of serious MRSA infection?

Current opinion in infectious diseases, 2014, Volume: 27, Issue:6

Topics: Acetamides; Anti-Bacterial Agents; Cephalosporins; Cost-Benefit Analysis; Drug Administration Routes; Drug Therapy, Combination; Glycopeptides; Humans; Linezolid; Lipoglycopeptides; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Oxazolidinones; Severity of Illness Index; Skin Diseases, Bacterial; Staphylococcal Infections; Tetrazoles; Vancomycin

2014

Systematic review and network meta-analysis of tedizolid for the treatment of acute bacterial skin and skin structure infections caused by MRSA.

BMC infectious diseases, 2017, 01-07, Volume: 17, Issue:1

Topics: Anti-Bacterial Agents; Bayes Theorem; Ceftaroline; Cephalosporins; Daptomycin; Humans; Linezolid; Methicillin-Resistant Staphylococcus aureus; Organophosphates; Oxazoles; Oxazolidinones; Skin Diseases, Bacterial; Staphylococcal Infections; Tetrazoles; Vancomycin

2017

Other Studies

1 other study(ies) available for cephalosporin c and tedizolid

Article	Year
Quasiexperimental intervention study protocol to optimise the use of new antibiotics in Spain: the NEW_SAFE project. BMJ open, 2020, 07-31, Volume: 10, Issue:7 Topics: Antimicrobial Stewardship; Azabicyclo Compounds; Ceftaroline; Ceftazidime; Cephalosporins; Clinical Protocols; Drug Combinations; Humans; Interrupted Time Series Analysis; Medication Systems; Oxazolidinones; Practice Patterns, Physicians'; Spain; Tazobactam; Teicoplanin; Tetrazoles	2020

Article

Year

Quasiexperimental intervention study protocol to optimise the use of new antibiotics in Spain: the NEW_SAFE project.

BMJ open, 2020, 07-31, Volume: 10, Issue:7

Topics: Antimicrobial Stewardship; Azabicyclo Compounds; Ceftaroline; Ceftazidime; Cephalosporins; Clinical Protocols; Drug Combinations; Humans; Interrupted Time Series Analysis; Medication Systems; Oxazolidinones; Practice Patterns, Physicians'; Spain; Tazobactam; Teicoplanin; Tetrazoles

2020